Clinical Practice Use
On-demand arrhythmia screening
Palpitations asessment
ST segment evaluation
Medicine and procedure impact reviews
Chronic illness support
Pre-diabetes screening
Drug-stratified cardiac trajectory monitoring
ecgme® is a Class IIa Medical Device
Integrated with practice management systems
How ecgme® improves Primary Care
Palpitations are among the most common cardiovascular presentations in Australian general practice. While most cases are benign, a clinically significant proportion involves arrhythmias that require timely identification and intervention.
ecgme® is a Class IIa medical device, a single-lead, hand-held ECG event recorder designed for instant cardiac rhythm assessments during medical consultations. Its portability and simplicity enable point-of-care ECG recordings that can be performed by clinical or non-clinical staff, even before a patient sees the doctor.
2024 Health Medical Conference
Biosignals Diagnostics participated in the 2024 Healthed Medical Update Conference and was honoured to be voted Champion, with 600 GPs rating ecgme® as follows:
For solving significant challenges in general practice
Making a difference in patient care
For improving admin and financial efficiency
Specialists
Our Clinical Practices Channel
Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.
Clinical Sector | The Gap - What's Missing Today | What Context-Aware Monitoring Delivers |
|---|---|---|
Remote Patient Monitoring (Cardiology) | Holter monitor runs 24–48 hrs. Paroxysmal arrhythmias are often not found in the short diagnostic window of Holter monitoring. No longitudinal assessment of ECG or contextual analysis with concurrent medications or comorbidities.
| Drug-aware classification: rate changes interpreted against medication profile. Longitudinal baseline detects deviation from the patient’s own normal. Cardiologist reviews trend, not just a snapshot. |
Diabetes / CAN | Cardiac autonomic neuropathy (CAN) is clinically silent until advanced. Heart rhythm segment intervals and HRV are affected by glycemic control and insulin regimen. No standard monitoring captures all concurrently. | HRV monitored in the context of HbA1c trajectory and insulin changes. Pattern deviation triggers alert before clinical symptoms. Closes the ‘silent CAN’ detection gap in primary care. |
Dialysis / Renal | HD patients undergo 2.2M sessions/yr in Australia. Intradialytic cardiac events go unmonitored. Fluid shifts, electrolyte changes, and EPO affect cardiac rhythm. | Continuous ECG during dialysis with session context (fluid removal volume, pre/post electrolytes). QT prolongation and ectopic burden mapped to session parameters. Supports institutional compliance reporting. |
Cardio-Oncology
| Ibrutinib, ADT, and anthracyclines carry direct cardiotoxicity risk. Oncology teams monitor tumour response; cardiac monitoring is episodic and not linked to treatment sequencing, drug cycles or cumulative dose. | ECG monitoring keyed to treatment cycle and cumulative drug exposure. QTc prolongation and ejection fraction signals interpreted in drug context. Enables earlier dose modification before irreversible damage. |
Psychotropic / QTc + ADHD
| Clozapine, SGAs, and ADHD stimulants carry QTc prolongation and arrhythmia risk. GP prescribes the drug; cardiac monitoring is rarely triggered. 52% of scripts written by GPs with no cardiology link. | QTc monitoring anchored to the specific drug, dose, and duration. GP receives structured alert when QTc ramps or breaches threshold. Closes the compliance and prescriber liability gap at point of care. |
Case Studies
Positive impact is being made with ecgme in clinical use, and Biosignals is delighted to share the following two cases of actual patients under management of Cardiologist and A/Prof. Stephan Foy.
Lynn, a 64 year old woman has episodes of palpitations that she describes as her “heart missing a beat”. These are intermittent and most often noticeable at night. The episodes can continue for many hours. She often has an elevated heart rate during these episodes. It seems to precipitate a cough. The episodes result in anxiety about her heart health. She was advised that ECG showed ectopic beats, but with her more frequent and prolonged episodes she has never had ECG confirmation of the episodes. I recommended she acquire an ecgme device from www.biosigdx.com to provide her with the confidence of recording her heart rhythm, so as to provide herself with reassurance. Some months later, she returned to see me with multiple recordings on her “ecgme” device that show atrial and ventricular ectopic beats during her episodes of palpitations. One recording shows a sinus pause of a few seconds duration. We discussed the benign nature of her ectopic beats, which she feels will go a long way to reducing her anxiety. She was advised that asymptomatic and infrequent brief pauses are of no immediate concern, but if these become longer or symptomatic, she will require permanent pacemaker.
Phil, 73 year old man has been experiencing infrequent palpitations that were more frequent during the colder months. He does not have any untoward symptoms during palpitation episodes; no dizziness, no black out. I spoke with him in October about recording his ECG during an episode and advised that he obtain a TGA approved hand held ECG event monitor (ecgme) from www.biosigdx.com. He has had one episode of palpitation since obtaining his ecgme device and recorded the event in December. The PDF of 30s recording was sent to me as a text message; it confirms atrial fibrillation. He was commenced on an anticoagulant to reduce his risk of stroke due to paroxysmal atrial fibrillation. He contacted me 3 months later, thanking me for the “health confidence” that he has gained with a confirmed diagnosis and appropriate treatment. He stated that he had just completed his longest ocean swim, 3.8km; the event is now an annual family tradition. The company appreciates Stephan sharing these two examples of how ecgme® is making a difference in clinical care.
Clinicians Enquiry Form
Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.